SKI Market

Indian Indices

Nifty

25,910.05 30.90
(0.12%)

Sensex

84,562.78 84.11
( 0.10%)

Bank Nifty

58,517.55 135.60
( 0.23%)

Nifty IT

36,301.25 -378.20
( -1.03%)

Global Indices

Nasdaq

47,163.83 -314.39
(-0.66%)

Dow Jones

6,754.35 -4.14
(-0.06%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,693.83 -113.85
(-1.16%)

Forex

USD-INR

88.59 -0.09
(-0.10%)

EUR-INR

102.60 0.08
(0.08%)

GBP-INR

116.32 -0.42
(-0.36%)

JPY-INR

0.57 0.00
(-0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

33.4345311

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.86

101.31

EPS(TTM)

Face Value()

Div & Yield %

8.66

Back

Ganesh Benzoplast standalone net profit rises 42.31% in the September 2025 quarter

Nov 14,2025

Net profit of Ganesh Benzoplast rose 42.31% to Rs 20.92 crore in the quarter ended September 2025 as against Rs 14.70 crore during the previous quarter ended September 2024. Sales rose 13.45% to Rs 61.65 crore in the quarter ended September 2025 as against Rs 54.34 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	61.65	54.34	13
OPM %	28.21	39.79	-
PBDT	23.34	24.44	-5
PBT	18.31	19.70	-7
NP	20.92	14.70	42

25,910.05 30.90 (0.12%)

84,562.78 84.11 ( 0.10%)

58,517.55 135.60 ( 0.23%)

36,301.25 -378.20 ( -1.03%)

47,163.83 -314.39 (-0.66%)

6,754.35 -4.14 (-0.06%)

50,333.56 -948.27 (-1.85%)

9,693.83 -113.85 (-1.16%)

88.59 -0.09 (-0.10%)

102.60 0.08 (0.08%)

116.32 -0.42 (-0.36%)

0.57 0.00 (-0.52%)